RADHAKISHAN PHARMACEUTICALS
BDENZA ENZULTAMIDE CAPSULES

BDENZA ENZULTAMIDE CAPSULES

BDENZA ENZULTAMIDE CAPSULES Specification

  • Indication
  • Metastatic castration-resistant prostate cancer
  • Pacakaging (Quantity Per Box)
  • 28 capsules per box
  • Origin of Medicine
  • India
  • Dosage Form
  • Capsule
  • Salt Composition
  • Enzalutamide 40 mg
  • Drug Type
  • Anticancer medicine
  • Ingredients
  • Enzalutamide
  • Physical Form
  • Capsule
  • Function
  • Androgen receptor inhibitor
  • Recommended For
  • Prostate cancer treatment
  • Dosage
  • As advised by physician
  • Dosage Guidelines
  • Take orally, follow medical prescription
  • Suitable For
  • Adults
  • Quantity
  • 40 mg
  • Storage Instructions
  • Store below 30C, protected from light and moisture
  • Side Effects
  • Fatigue, hot flashes, hypertension, seizure risk
  • Expiry
  • 24 months from date of manufacture
  • Administration Route
  • Oral
  • Minimum Order Quantity
  • 1 box
  • HSN Code
  • 30049099
  • Prescription Status
  • Prescription only
  • Precautions
  • Monitor liver function, avoid driving or operating machinery
  • Therapeutic Class
  • Oncology
  • Brand Name
  • BDENZA
  • Contraindications
  • Hypersensitivity to Enzalutamide
  • Colour
  • White capsules
  • Marketed By
  • BD Biosciences
  • Warning
  • Not to be used in female patients, children or adolescents
 

BDENZA ENZULTAMIDE CAPSULES Trade Information

  • Packaging Details
  • PACK OF 28 CAPSULES
  • Main Domestic Market
  • All India
 

About BDENZA ENZULTAMIDE CAPSULES

Bdenza Capsules

Specifications:-

  • Manufactured by:BDR Pharmaceutical
  • Strength:40 mg
  • Composition:Enzalutamide
  • Packaging Size:28 capsule per blister (28x4)
  • Form:capsules
  • Brand:BDENZA


Note :-BDENZA Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..........




Effective Prostate Cancer Management

BDENZA is specifically indicated for metastatic castration-resistant prostate cancer. Its androgen receptor inhibition mode targets the diseases progression, providing significant clinical benefit for eligible patients when administered under professional supervision.


Strict Usage and Safety Precautions

This medication requires careful adherence to medical instructions. Regular liver monitoring, avoidance of driving or heavy machinery, and attention to possible side effects like fatigue or hypertension are pivotal to patient safety during treatment.


Convenient Packaging and Proven Origin

Each BDENZA box contains 28 capsules and is distributed by BD Biosciences in India. Its 24-month shelf life facilitates flexible procurement for hospital, export, or wholesale needs, ensuring quality and efficacy remain intact.

FAQs of BDENZA ENZULTAMIDE CAPSULES:


Q: How should BDENZA Enzalutamide Capsules be taken?

A: BDENZA capsules are taken orally, exactly as prescribed by your physician. Follow the recommended dosage and do not make adjustments without medical advice.

Q: What is the therapeutic benefit of BDENZA for patients?

A: BDENZA is used to manage metastatic castration-resistant prostate cancer by inhibiting androgen receptors, which helps slow disease progression and improve patient outcomes.

Q: When should BDENZA not be used?

A: BDENZA should not be used in female patients, children, adolescents, or individuals with hypersensitivity to Enzalutamide. Consult your physician if you have any concerns about underlying conditions.

Q: Where should BDENZA capsules be stored?

A: Store BDENZA capsules below 30C, in a dry place protected from light and moisture, to preserve efficacy throughout the 24-month shelf life.

Q: What monitoring is required during BDENZA treatment?

A: Patients should have regular liver function tests and avoid activities like driving or operating machinery due to potential side effects, as advised by their doctor.

Q: What side effects may occur with BDENZA?

A: Possible side effects include fatigue, hot flashes, hypertension, and in rare cases, an increased risk of seizures. Report any adverse reactions to your healthcare provider promptly.

Q: Who can supply BDENZA Enzalutamide Capsules in India and abroad?

A: BDENZA is marketed by BD Biosciences and is available through approved distributors, exporters, suppliers, traders, and wholesalers across India and for international markets.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

DESIFER DEFERASIROX TABLETS

DESIFER DEFERASIROX TABLETS

Minimum Order Quantity : 1 Bottle

Indication : Treatment of chronic iron overload in patients receiving longterm blood transfusions

Drug Type : Other Types

Ingredients : Deferasirox

Dosage Guidelines : As directed by the physician

Recommended For : Patients with chronic iron overload due to frequent blood transfusions

Dorucin Doxorubicin Hydrochloride Injection

Dorucin Doxorubicin Hydrochloride Injection

Minimum Order Quantity : 1 Bottle

Indication : Used for various types of cancers including breast cancer, leukemia, lymphomas

Drug Type : Other, Prescription

Ingredients : Doxorubicin Hydrochloride

Dosage Guidelines : As directed by the physician

Recommended For : Hospital and Clinical Use

ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS

ABIRAKAST ABIRATERONE ACETATE 250 MG TABLETS

Minimum Order Quantity : 1 Bottle

Indication : Metastatic castrationresistant prostate cancer (mCRPC)

Drug Type : Other, Allopathic

Ingredients : Abiraterone Acetate

Dosage Guidelines : Should be taken on an empty stomach, at least one hour before or two hours after food

Recommended For : Prostate Cancer Patients

VELPANAT SOFOSBUVIR  VELPATASAVIR TABLETS

VELPANAT SOFOSBUVIR VELPATASAVIR TABLETS

Indication : Treatment of chronic HCV genotypes 1, 2, 3, 4, 5, or 6

Drug Type : Other, Allopathic

Ingredients : sofosbuvir

Dosage Guidelines : As directed by physician; usually one tablet once daily with or without food

Recommended For : Chronic Hepatitis C Virus (HCV) infection



Back to top